Does OMALIZUMAB Cause Administration site erythema? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Administration site erythema have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.0% of all adverse event reports for OMALIZUMAB.
16
Reports of Administration site erythema with OMALIZUMAB
0.0%
of all OMALIZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Administration site erythema From OMALIZUMAB?
Of the 16 reports, 4 (25.0%) required hospitalization.
Is Administration site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Administration site erythema?
HUMAN IMMUNOGLOBULIN G (87)
MORPHINE (19)
CEFADROXIL (14)
CLONAZEPAM (14)
HYDROMORPHONE (14)
MECLOZINE (14)
NIACIN (14)
PAROXETINE (14)
EPOPROSTENOL (8)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (8)
Which OMALIZUMAB Alternatives Have Lower Administration site erythema Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS